Growth Metrics

Mannkind (MNKD) Total Liabilities (2010 - 2026)

Mannkind (MNKD) reported Total Liabilities of $803.6 million for Q1 2026, up 71.43% year-over-year from $468.8 million in Q1 2025, and down 4.7% on a QoQ basis from $843.2 million in Q4 2025.

Mannkind (MNKD) has 17 years of Total Liabilities data on file, last reported at $803.6 million in Q1 2026.

  • Quarterly Total Liabilities rose 71.43% year-over-year to $803.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $803.6 million (up 71.43% YoY) and the FY2025 annual result came in at $843.2 million, up 78.4% from the prior year.
  • Total Liabilities fell to $803.6 million in Q1 2026 per MNKD's latest filing, from $843.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $843.2 million in Q4 2025 and bottomed at $145.8 million in Q4 2023.
  • The 5-year median for Total Liabilities is $547.0 million (2022), against an average of $568.7 million.
  • The widest annual swing landed in 2024, when Total Liabilities soared 224.16%; it then sank 34.06% in 2025.
  • Tracing MNKD's Total Liabilities over 5 years: stood at $531.5 million in 2022, then plunged by 72.57% to $145.8 million in 2023, then soared by 224.16% to $472.7 million in 2024, then jumped by 78.4% to $843.2 million in 2025, then retreated by 4.7% to $803.6 million in 2026.
  • Per Business Quant, the three latest MNKD Total Liabilities figures stand at $803.6 million (Q1 2026), $843.2 million (Q4 2025), and $539.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 803.60 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 803.60 Mn
Dec 31, 2025 843.20 Mn
Sep 30, 2025 539.19 Mn
Jun 30, 2025 466.74 Mn
Mar 31, 2025 468.76 Mn
Dec 31, 2024 472.66 Mn
Sep 30, 2024 674.13 Mn
Jun 30, 2024 669.62 Mn
Mar 31, 2024 710.85 Mn
Dec 31, 2023 145.81 Mn
Sep 30, 2023 572.11 Mn
Jun 30, 2023 573.91 Mn
Mar 31, 2023 553.53 Mn
Sep 30, 2022 531.51 Mn
Jun 30, 2022 532.85 Mn
Mar 31, 2022 540.38 Mn
Dec 31, 2021 530.51 Mn
Sep 30, 2021 422.90 Mn
Jun 30, 2021 436.34 Mn
Mar 31, 2021 493.00 Mn
Dec 31, 2020 289.03 Mn
Sep 30, 2020 282.10 Mn
Jun 30, 2020 282.49 Mn
Mar 31, 2020 278.26 Mn
Dec 31, 2019 284.25 Mn
Sep 30, 2019 279.85 Mn
Jun 30, 2019 277.79 Mn
Mar 31, 2019 288.97 Mn
Dec 31, 2018 282.79 Mn
Sep 30, 2018 250.80 Mn
Jun 30, 2018 268.77 Mn
Mar 31, 2018 285.09 Mn
Dec 31, 2017 299.31 Mn
Sep 30, 2017 307.50 Mn
Jun 30, 2017 300.62 Mn
Mar 31, 2017 283.91 Mn
Dec 31, 2016 290.66 Mn
Sep 30, 2016 334.82 Mn
Jun 30, 2016 506.01 Mn
Mar 31, 2016 466.74 Mn
Dec 31, 2015 476.74 Mn
Sep 30, 2015 402.58 Mn
Jun 30, 2015 468.03 Mn
Mar 31, 2015 457.05 Mn
Dec 31, 2014 468.21 Mn
Sep 30, 2014 427.50 Mn
Jun 30, 2014 282.68 Mn
Mar 31, 2014 207.02 Mn
Dec 31, 2013 289.36 Mn
Sep 30, 2013 455.33 Mn
Jun 30, 2013 364.79 Mn
Mar 31, 2013 362.00 Mn
Dec 31, 2012 361.99 Mn
Sep 30, 2012 486.58 Mn
Jun 30, 2012 484.77 Mn
Mar 31, 2012 528.81 Mn
Dec 31, 2011 513.21 Mn
Sep 30, 2011 504.82 Mn
Jun 30, 2011 473.74 Mn
Dec 31, 2010 462.79 Mn